Certara Inc stock is traded at $10.55, with a volume of 2,781,226. It is down -1.22% in the last 24 hours and up +7.82% over the past month. Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
Previous Close:
$10.68
Open:
$10.56
24h Volume:
2,781,226
Relative Volume:
0.95
Market Cap:
$1.61B
Revenue:
$419.75M
Net Income/Loss:
-$15.10M
P/E Ratio:
-
EPS:
-$0.0953
Net Cash Flow:
$63.10M
1W Performance:
-8.82%
1M Performance:
+7.82%
6M Performance:
+125.91%
1Y Performance:
+31.38%
1-Day Range:
$10.42$10.86
1-Week Range:
$10.42$11.54
52-Week Range:
$4.45$12.61
Certara Inc Stock (CERT) Company Profile
Name
Certara IncSector
HealthcareIndustry
Health Information ServicesPhone
(415) 237-8272Address
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS